ST. LOUIS (KMOX) – A new type of cholesterol lowering drug works wonders in high risk heart patients.

SLU Care cardiologist Dr. Michael Lim at SSM Health SLU Hospital says this expensive new injectable drug is call Repatha.

“So the results of this study showed that on top of the cholesterol lowering therapy with Statin, the new drug, the PCSK9 inhibitor decreased cholesterol by another 59 percent,” he says.

The drug is available now, but Lim says price is a big issue at nearly $15 thousand a year with many insurance companies reluctant to pay for it.

Follow us on Twitter | Like us on Facebook


Leave a Reply

Please log in using one of these methods to post your comment:

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

Listen Live